![]() |
|
|
Craft Technologies, Inc., Wilson, NC 27893
3To whom correspondence should be addressed. E-mail: ncraft{at}crafttechnologies.com
The health and sight of millions of children are compromised each year as a consequence of vitamin A (VA) deficiency. Serum retinol is the most commonly used indicator of VA status. Unfortunately, its use is impractical for national surveys because it involves collection of venous blood, centrifugation and frozen storage before analysis. To make VA assessment more practical, we have developed approaches incorporating dried blood spots (DBS) or portable instrumentation. DBS have been used as a sample matrix to screen neonates for many biochemical compounds. Until recently, it was not thought that VA was stable in DBS. However, we demonstrated that the measure of DBS retinol correlates well with serum retinol in both healthy adults (r2 = 0.880.90) and compromised populations (r2 = 0.730.84). Compared with serum retinol, the sensitivity and specificity of detecting VA deficiency by DBS retinol range from 73 to 93% and from 90 to 100%, respectively. Although few data are available, retinol binding protein (RBP) can also be measured in DBS. RBP has been used as a surrogate marker for serum retinol. Correlations coefficients (r2) between serum RBP and serum retinol range from 0.4 to 0.8. In addition, work has been done to develop portable instrumentation to measure VA status in the field. A fluorometer has been optimized for VA fluorescence and is linear into the deficient range for the direct fluorimetric measurement of serum holo-RBP. Progress is being made to use the instrument to directly measure holo-RBP in a drop of whole blood.
KEY WORDS: vitamin A assessment dried blood spot retinol binding protein fluorometry enzyme immunological assay high performance liquid chromatography
This article has been cited by other articles:
![]() |
J. M. Fernandez-Real, J. M. Moreno, and W. Ricart Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance-Associated Iron Overload Diabetes, July 1, 2008; 57(7): 1918 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujita, E. Brindle, J. Shofer, P. Ndemwa, Y. Kombe, B. Shell-Duncan, and K. A. O'Connor Retinol-Binding Protein Stability in Dried Blood Spots Clin. Chem., November 1, 2007; 53(11): 1972 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hix, C. Martinez, I. Buchanan, J. Morgan, M. Tam, and A. Shankar Development of a rapid enzyme immunoassay for the detection of retinol-binding protein Am. J. Clinical Nutrition, January 1, 2004; 79(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Furr Analysis of Retinoids and Carotenoids: Problems Resolved and Unsolved J. Nutr., January 1, 2004; 134(1): 281S - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Tanumihardjo Assessing Vitamin A Status: Past, Present and Future J. Nutr., January 1, 2004; 134(1): 290S - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Coté Noninvasive and Minimally-Invasive Optical Monitoring Technologies J. Nutr., May 1, 2001; 131(5): 1596S - 1604. [Abstract] [Full Text] |
||||
![]() |
J. D. Hirschman and J. A. Kresge Synthesis of a Symposium: Innovative Non- or Minimally-Invasive Technologies for Monitoring Health and Nutritional Status in Mothers and Young Children J. Nutr., May 1, 2001; 131(5): 1643S - 1645. [Full Text] |
||||